CAMBRIDGE, MASS.--(BUSINESS WIRE)--Seaside Therapeutics LLC announced today the addition of three highly experienced industry executives to the Company’s senior management team—Daniel E. Geffken as Chief Operating Officer, John C. Amedio, Jr., Ph.D., as Vice President, Manufacturing and Process Development and W. Roger Rush, Ph.D., as Vice President, Preclinical Development.
